Open AccessTreatment with Brusatol inhibits oncogenic transcription factors NRF2 and TAZ, reducing glioma stem cells survival.
Author(s) -
Diego Lastra,
Marta Pajares,
Natalia Robledinos-Antón,
Antonio Cuadrado,
Maribel Escoll,
Ricardo Gargini
Publication year - 2018
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.18v1s1.00030
Subject(s) - pharmacogenetics , glioblastoma , cancer research , pharmacology , glioma , drug , medicine , biology , gene , genetics , genotype